Keranova Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Keranova General Information

Description

Developer of surgical instruments designed to supplant existing semi-manual, operator-dependent surgical procedures in ophthalmic surgery. The company's instruments allow an approach to offering anterior segment surgery reproducible through automated equipment possessing vision, intelligent software, and precise robotic movements, enabling doctors to substantially reduce manual intervention in favor of automation.

Contact Information

Website
www.keranova.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 109 rue de la Montat
  • Le Ginkgo
  • 42000 Saint-Étienne
  • France
+33 04
Primary Industry
Surgical Devices
Vertical(s)
Corporate Office
  • 109 rue de la Montat
  • Le Ginkgo
  • 42000 Saint-Étienne
  • France
+33 04

Keranova Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keranova Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Oct-2025 Completed Generating Revenue
4. Later Stage VC (Series B) 10-Oct-2023 Completed Generating Revenue
3. Accelerator/Incubator 01-Sep-2021 Completed Generating Revenue
2. Early Stage VC (Series B) 10-Sep-2019 $26.6M $32.2M Completed Generating Revenue
1. Early Stage VC (Series A) 11-Apr-2016 $5.64M $5.64M Completed Generating Revenue
To view Keranova’s complete valuation and funding history, request access »

Keranova Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ADP B
Series B
Series A 62,857 $1.061853 $74.33 $74.33 1x $74.33 31.89%
To view Keranova’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Keranova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of surgical instruments designed to supplant existing semi-manual, operator-dependent surgical procedures in o
Surgical Devices
Saint-Étienne, France
29 As of 2026

Eindhoven, Netherlands
 

Lake Forest, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Keranova Competitors (2)

One of Keranova’s 2 competitors is Preceyes, a Formerly VC-backed company based in Eindhoven, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Preceyes Formerly VC-backed Eindhoven, Netherlands
Altaviz Corporation Lake Forest, CA
You’re viewing 2 of 2 competitors. Get the full list »

Keranova Patents

Keranova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026166931-A1 Method and device for determining an optimal position for making an incision in a cornea of a patient Pending 04-Feb-2025
FR-3171770-A1 Method and device for determining an optimal position for performing an incision in a patient's cornea Pending 04-Feb-2025
FR-3142882-A1 System for cutting eye tissue into elementary portions Active 12-Dec-2022
EP-4633564-A1 System for cutting ocular tissue into elementary portions Pending 12-Dec-2022
FR-3142882-B1 System for cutting ocular tissue into elementary portions Active 12-Dec-2022 A61F9/00825
To view Keranova’s complete patent history, request access »

Keranova Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keranova Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pulsalys Accelerator/Incubator Minority
Financiere Arbevel PE-Backed Company Minority
Supernova Invest Venture Capital Minority
Tourrette Investissements PE/Buyout Minority
Merieux Equity Partners (Lyon) PE/Buyout Minority
To view Keranova’s complete investors history, request access »

Keranova FAQs

  • When was Keranova founded?

    Keranova was founded in 2015.

  • Where is Keranova headquartered?

    Keranova is headquartered in Saint-Étienne, France.

  • What is the size of Keranova?

    Keranova has 29 total employees.

  • What industry is Keranova in?

    Keranova’s primary industry is Surgical Devices.

  • Is Keranova a private or public company?

    Keranova is a Private company.

  • What is Keranova’s current revenue?

    The current revenue for Keranova is .

  • How much funding has Keranova raised over time?

    Keranova has raised $36.6M.

  • Who are Keranova’s investors?

    Pulsalys, Financiere Arbevel, Supernova Invest, Tourrette Investissements, and Merieux Equity Partners (Lyon) have invested in Keranova.

  • Who are Keranova’s competitors?

    Preceyes and Altaviz are competitors of Keranova.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process